Found: 8
Select item for more details and to access through your institution.
An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Comparison of ¹²³I-metaiodobenzylguanidine (MIBG) and ¹³¹I-MIBG semi-quantitative scores in predicting survival in patients with stage 4 neuroblastoma: a report from the Children's Oncology Group.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Thyroid and hepatic function after high-dose 131 I-metaiodobenzylguanidine (131 I-MIBG) therapy for neuroblastoma.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Outcome of high-risk stage 3 neuroblastoma with myeloablative therapy and 13-cis-retinoic acid: a report from the Children's Oncology Group.
- Published in:
- 2009
- By:
- Publication type:
- journal article
A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
- Published in:
- 2005
- By:
- Publication type:
- Journal Article
Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
- Published in:
- 2012
- By:
- Publication type:
- journal article